Xuerong Biotech (300511.SZ) issued an announcement. The company received it from the Shanghai Securities Regulatory Bureau on December 25, 2023...
Zhitong Finance App News, Xuerong Biotech (300511.SZ) issued an announcement. The company received the “Decision on Ordering Corrective Measures against Shanghai Xuerong Biotechnology Co., Ltd.”, “Decision on Issuing Warning Letter Measures against Yang Yongping”, and “Decision on Measures to Issue a Warning Letter against Chen Xiong” issued by the Shanghai Securities Regulatory Bureau on December 25, 2023.
According to reports, there were calculation errors and improper forecasting methods in the impairment test of the asset group of the wholly-owned subsidiary Weining Xiangrong Biotechnology Co., Ltd. in 2020-2022, the impairment test was inaccurate, and did not comply with the relevant provisions of “Corporate Accounting Standard No. 8 - Asset Impairment”, resulting in inaccurate financial data disclosed in the corresponding annual periodic report. The above acts violate the provisions of Article 2 (1) of the “Administrative Measures on Information Disclosure of Listed Companies” (CSRC Order No. 40) and Article 3 (1) of the “Administrative Measures on Information Disclosure of Listed Companies” (CSRC Order No. 182).
Yang Yongping has been the chairman of the company since August 2014, and is also the company's general manager and in charge of accounting work since April 2022. He has not been diligent and conscientious in carrying out his duties. He is responsible for the above matters, and violates the provisions of section 3 of the “Administrative Measures on Information Disclosure of Listed Companies” (Securities Regulatory Commission Order No. 40) and section 4 of the “Administrative Measures on Information Disclosure of Listed Companies” (Securities Regulatory Commission Order No. 182). Chen Xiong was the financial director of the company from August 2018 to April 2022. He was not diligent and conscientious in carrying out his duties. He was responsible for the company's above matters, and violated the provisions of section 3 of the “Administrative Measures on Information Disclosure of Listed Companies” (CSRC Order No. 40) and section 4 of the “Administrative Measures on Information Disclosure of Listed Companies” (CSRC Order No. 182).